ClinicalTrials.Veeva

Menu

The Necessity and Optimal Time for Performing Pars Plana Vitrectomy in Acute Retinal Necrosis Patients

C

Chongqing Medical University

Status

Completed

Conditions

Acute Retinal Necrosis

Treatments

Procedure: pars plana vitrectomy

Study type

Observational

Funder types

Other

Identifiers

NCT03260049
ChongqingMU-2

Details and patient eligibility

About

The records of patients who were diagnosed with ARN between April 2010 and February 2017 were analyzed.A retrospective review of the treatment options and outcomes of the these patients was performed.

Enrollment

30 patients

Sex

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ARN was diagnosed according to the American Uveitis Society Diagnostic Criteria (1994)

Exclusion criteria

Trial design

30 participants in 3 patient groups

1
Description:
there was no retinal detachment (RD) at the first visit. The group 1 patients were treated with systemic antiviral medications, as well as with intravitreal antiviral injections
2
Description:
there was no RD at the first visit. The group 2 patients were treated with systemic antiviral medications and PPV plus silicone oil tamponade and intravitreal injection.
Treatment:
Procedure: pars plana vitrectomy
3
Description:
there was RD at the first visit. The group 3 patients were treated with systemic antiviral medications and PPV plus silicone oil tamponade and intravitreal injection
Treatment:
Procedure: pars plana vitrectomy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems